Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,448.00    8.00 (0.56%)
Bid:
1,444.00
Ask:
1,448.00
Spread: 4.00 (0.277%)
Market Cap: £495.75m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results
7th Jul 20226:13 pmRNSHolding(s) in Company
27th Apr 20221:00 pmRNSBoard Appointment
14th Apr 202212:35 pmRNSBlock listing Interim Review
31st Mar 20224:09 pmRNSTotal Voting Rights
25th Mar 20222:16 pmRNSDividend Currency Election
22nd Mar 20221:37 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Payment Date Update
14th Mar 20227:00 amRNSInterim Results
7th Mar 20225:20 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSBlocklisting Application
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Update and Notice of Results
26th Nov 20215:05 pmRNSDividend Currency Election
19th Nov 20212:46 pmRNSGrant of Long Term Incentive Plan Awards
16th Nov 20212:09 pmRNSResult of AGM
16th Nov 20217:00 amRNSAGM Statement and Integration Update
19th Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Oct 20213:37 pmRNSBlock listing Interim Review
22nd Sep 202112:52 pmRNSPurchase of Shares
21st Sep 20215:58 pmRNSDividend Timetable
21st Sep 20217:00 amRNSFinal Results
20th Jul 20214:53 pmRNSHolding(s) in Company
14th Jul 20215:19 pmRNSHolding(s) in Company
13th Jul 20217:00 amRNSCompletion of SDS Holdco, Inc. Acquisition
13th Jul 20217:00 amRNSTrading Update and Notice of Results
18th Jun 202111:42 amRNSHolding(s) in Company
14th Jun 202110:01 amRNSHolding(s) in Company
10th Jun 202111:55 amRNSHolding(s) in Company
10th Jun 202111:53 amRNSDirector/PDMR Share Dealings
8th Jun 20214:40 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20219:05 amRNSSecond Price Monitoring Extn
8th Jun 20219:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSResults of Placing and Total Voting Rights
7th Jun 20215:27 pmRNSProposed Placing
7th Jun 20215:25 pmRNSAcquisition of SDS Holdco, Inc.
15th Apr 20217:00 amRNSBlock listing Interim Review
19th Mar 20211:05 pmRNSDividend Currency Election
1st Mar 20217:00 amRNSInterim Results
20th Jan 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.